(AC) Accor S. A. - Overview
Stock: Hotel, Brand, Franchise, Service, Reservation
Dividends
| Dividend Yield | 2.77% |
| Yield on Cost 5y | 4.42% |
| Yield CAGR 5y | 9.54% |
| Payout Consistency | 86.5% |
| Payout Ratio | 56.3% |
| Risk 5d forecast | |
|---|---|
| Volatility | 21.7% |
| Relative Tail Risk | -2.80% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.02 |
| Alpha | -7.70 |
| Character TTM | |
|---|---|
| Beta | 0.386 |
| Beta Downside | 0.531 |
| Drawdowns 3y | |
|---|---|
| Max DD | 28.42% |
| CAGR/Max DD | 0.73 |
Description: AC Accor S. A. January 03, 2026
Accor SA (ticker AC) is a French-based, globally diversified hotel operator that runs three core segments: Premium/Midscale/Economy (brands such as Ibis, Novotel, Mercure, Swissôtel, Mövenpick, Pullman) and Luxury & Lifestyle (Raffles, Fairmont, Sofitel, MGallery, Ennismore). The group owns, leases, manages, and franchises hotels across Europe, North Africa, the Middle East, Africa, APAC, the Americas and China, and supplements its core lodging business with ancillary services-including discount card programs, catering, event management, digital booking platforms, concierge, fine-dining, entertainment, luxury residence rentals, coworking spaces, and a suite of back-office services (procurement, cash-management, IT, advertising, and advisory).
Key quantitative drivers to watch: (1) RevPAR (Revenue per Available Room) grew 12% YoY in FY 2023, driven by a 9% rise in average daily rate (ADR) and a 3% lift in occupancy as travel demand recovered post-pandemic; (2) Accor’s asset-light model now accounts for roughly 70% of its portfolio, limiting capital-intensive exposure while expanding franchise fees, which rose 15% YoY; (3) The company’s pipeline includes over 500 hotels slated to open by 2026, with a notable concentration in high-growth markets such as China’s secondary cities and the Middle East, where tourism GDP growth averages 6-7% annually. Macro-level, the sector remains sensitive to discretionary spending trends, inflation-driven cost pressures, and the pace of global travel normalization, all of which introduce upside/downside volatility to Accor’s earnings outlook.
For a deeper, data-rich analysis of Accor’s valuation dynamics, you may find ValueRay’s platform useful as a next step.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 1.21b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 5.32 > 1.0 |
| NWC/Revenue: 2.97% < 20% (prev 13.88%; Δ -10.91% < -1%) |
| CFO/TA 0.13 > 3% & CFO 1.56b > Net Income 1.21b |
| Net Debt (3.15b) to EBITDA (2.22b): 1.42 < 3 |
| Current Ratio: 1.12 > 1.5 & < 3 |
| Outstanding Shares: last quarter (291.2m) vs 12m ago 9.95% < -2% |
| Gross Margin: 33.48% > 18% (prev 0.45%; Δ 3304 % > 0.5%) |
| Asset Turnover: 94.47% > 50% (prev 47.53%; Δ 46.93% > 0%) |
| Interest Coverage Ratio: 5.32 > 6 (EBITDA TTM 2.22b / Interest Expense TTM 307.0m) |
Altman Z'' 2.09
| A: 0.03 (Total Current Assets 3.08b - Total Current Liabilities 2.75b) / Total Assets 11.83b |
| B: 0.14 (Retained Earnings 1.66b / Total Assets 11.83b) |
| C: 0.14 (EBIT TTM 1.63b / Avg Total Assets 11.65b) |
| D: 0.48 (Book Value of Equity 3.42b / Total Liabilities 7.06b) |
| Altman-Z'' Score: 2.09 = BBB |
Beneish M -2.43
| DSRI: 0.49 (Receivables 899.0m/906.0m, Revenue 11.01b/5.45b) |
| GMI: 1.33 (GM 33.48% / 44.51%) |
| AQI: 1.03 (AQ_t 0.66 / AQ_t-1 0.64) |
| SGI: 2.02 (Revenue 11.01b / 5.45b) |
| TATA: -0.03 (NI 1.21b - CFO 1.56b) / TA 11.83b) |
| Beneish M-Score: -2.43 (Cap -4..+1) = BBB |
What is the price of AC shares?
Over the past week, the price has changed by +6.37%, over one month by +2.39%, over three months by +8.23% and over the past year by +0.32%.
Is AC a buy, sell or hold?
What are the forecasts/targets for the AC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 54.7 | 12.1% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 56.8 | 16.4% |
AC Fundamental Data Overview February 03, 2026
P/E Trailing = 20.4732
P/E Forward = 14.6628
P/S = 1.8922
P/B = 2.443
P/EG = 0.9907
Revenue TTM = 11.01b EUR
EBIT TTM = 1.63b EUR
EBITDA TTM = 2.22b EUR
Long Term Debt = 3.13b EUR (from longTermDebt, last quarter)
Short Term Debt = 575.0m EUR (from shortTermDebt, last quarter)
Debt = 4.28b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.15b EUR (from netDebt column, last quarter)
Enterprise Value = 13.88b EUR (10.74b + Debt 4.28b - CCE 1.14b)
Interest Coverage Ratio = 5.32 (Ebit TTM 1.63b / Interest Expense TTM 307.0m)
EV/FCF = 14.74x (Enterprise Value 13.88b / FCF TTM 942.0m)
FCF Yield = 6.79% (FCF TTM 942.0m / Enterprise Value 13.88b)
FCF Margin = 8.56% (FCF TTM 942.0m / Revenue TTM 11.01b)
Net Margin = 11.03% (Net Income TTM 1.21b / Revenue TTM 11.01b)
Gross Margin = 33.48% ((Revenue TTM 11.01b - Cost of Revenue TTM 7.32b) / Revenue TTM)
Gross Margin QoQ = 21.31% (prev 46.91%)
Tobins Q-Ratio = 1.17 (Enterprise Value 13.88b / Total Assets 11.83b)
Interest Expense / Debt = 1.66% (Interest Expense 71.0m / Debt 4.28b)
Taxrate = 21.10% (69.0m / 327.0m)
NOPAT = 1.29b (EBIT 1.63b * (1 - 21.10%))
Current Ratio = 1.12 (Total Current Assets 3.08b / Total Current Liabilities 2.75b)
Debt / Equity = 0.98 (Debt 4.28b / totalStockholderEquity, last quarter 4.35b)
Debt / EBITDA = 1.42 (Net Debt 3.15b / EBITDA 2.22b)
Debt / FCF = 3.34 (Net Debt 3.15b / FCF TTM 942.0m)
Total Stockholder Equity = 4.45b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.42% (Net Income 1.21b / Total Assets 11.83b)
RoE = 27.29% (Net Income TTM 1.21b / Total Stockholder Equity 4.45b)
RoCE = 21.55% (EBIT 1.63b / Capital Employed (Equity 4.45b + L.T.Debt 3.13b))
RoIC = 16.59% (NOPAT 1.29b / Invested Capital 7.77b)
WACC = 5.62% (E(10.74b)/V(15.02b) * Re(7.34%) + D(4.28b)/V(15.02b) * Rd(1.66%) * (1-Tc(0.21)))
Discount Rate = 7.34% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 7.44%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈686.4m ; Y1≈450.6m ; Y5≈205.6m
Fair Price DCF = 14.54 (EV 6.55b - Net Debt 3.15b = Equity 3.40b / Shares 234.1m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 50.24 | EPS CAGR: 119.8% | SUE: 0.0 | # QB: 0
Revenue Correlation: 78.40 | Revenue CAGR: 57.39% | SUE: 0.06 | # QB: 0
EPS next Year (2026-12-31): EPS=2.48 | Chg30d=-0.062 | Revisions Net=-6 | Growth EPS=+19.6% | Growth Revenue=+5.7%